Impact of non-coding RNAs on resistance to imatinib in chronic myelogenous leukemia. [PDF]
Ensafi Talemi F, Ghafouri-Fard S.
europepmc +1 more source
DNA self-assembly nanoflower reverse P-glycoprotein mediated drug resistance in chronic myelogenous leukemia therapy. [PDF]
Zhao P +8 more
europepmc +1 more source
Inhibition of autophagy enhances the sensitivity of ciclopirox olamine in human chronic myelogenous leukemia K562 cells. [PDF]
Zhou H, Chen H, Luo K, Kong L, Li Y.
europepmc +1 more source
Effect of asciminib and vitamin K2 on Abelson tyrosine-kinase-inhibitor-resistant chronic myelogenous leukemia cells. [PDF]
Okabe S, Gotoh A.
europepmc +1 more source
Research on the functions and potential mechanisms of STAT3 in chronic myelogenous leukemia. [PDF]
Feng X, Qin Y, Feng Y, Zhuo Y.
europepmc +1 more source
Chronic myelogenous leukemia following radiotherapy and chemotherapy for non-Hodgkin lymphoma.
We report here a women who developed chronic myelogenous leukemia (CML) after successful radiotherapy and chemotherapy for non-Hodgkin lymphoma. Review of the literature indicates that exposure to ionizing radiation is associated with an increased risk ...
CAZZOLA, MARIO +5 more
core
Uncommon phenotypes of <i>BCR::ABL1</i>-positive chronic myelogenous leukemia. [PDF]
Jajosky AN, Lichtman MA.
europepmc +1 more source
Methyl-Thiol-Bridged Oxadiazole and Triazole Heterocycles as Inhibitors of NF-κB in Chronic Myelogenous Leukemia Cells. [PDF]
Basappa B +9 more
europepmc +1 more source
CHRONIC MYELOGENOUS LEUKEMIA (CML) IN THE ELDERLY
Lodovico Balducci
doaj +1 more source

